Role of CXCR4 in the pathogenesis of acute myeloid leukemia.
about
Decreased expression of CXCR4 chemokine receptor in bone marrow after chemotherapy in patients with non-Hodgkin lymphomas is a good prognostic factorThe intricate role of CXCR4 in cancer.Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatinAntileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy.Improving chemotherapeutic efficiency in acute myeloid leukemia treatments by chemically synthesized peptide interfering with CXCR4/CXCL12 axis.Differential hypoxic regulation of the microRNA-146a/CXCR4 pathway in normal and leukemic monocytic cells: impact on response to chemotherapy.Targeted drug discovery for pediatric leukemia.Comparison of (18)F-labeled CXCR4 antagonist peptides for PET imaging of CXCR4 expression.CXCL12 retargeting of an adenovirus vector to cancer cells using a bispecific adapter.Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside.The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signalingPriming cancer cells for drug resistance: role of the fibroblast niche.Regulatory effect of chemokines in bone marrow niche.Emerging therapeutic targets for the treatment of human acute myeloid leukemia (part 1) - gene transcription, cell cycle regulation, metabolism and intercellular communication.Antigen-specific immunotherapy for acute myeloid leukemia: where are we now, and where do we go from here?ETV6-LPXN fusion transcript generated by t(11;12)(q12.1;p13) in a patient with relapsing acute myeloid leukemia with NUP98-HOXA9.Urokinase receptor and CXCR4 are regulated by common microRNAs in leukaemia cells.Drug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphoma.Chemokine (C-X-C motif) receptor 4 RNA interference inhibits bone metastasis in breast cancer.Breast tumor stroma: A driving force in the development of resistance to therapies.Transcriptome analysis of G protein-coupled receptors in distinct genetic subgroups of acute myeloid leukemia: identification of potential disease-specific targets.CXCR4 chemokine receptor overview: biology, pathology and applications in imaging and therapy.High expression of dedicator of cytokinesis 1 (DOCK1) confers poor prognosis in acute myeloid leukemia.The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression.Drug Repurposing for the Treatment of Acute Myeloid Leukemia.Overexpression of CXCR4 promotes invasion and migration of non-small cell lung cancer via EGFR and MMP-9.TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells.Therapeutic targeting of leukemic stem cells in acute myeloid leukemia - the biological background for possible strategies.Acute Myeloid Leukemia and the Bone Marrow Niche-Take a Closer LookFra-2 Expression in Osteoblasts Regulates Systemic Inflammation and Lung Injury through Osteopontin
P2860
Q33654957-7F06CC69-4332-4700-92E4-5A37F3CB28C5Q35067624-7D49ADA1-04E6-48A7-BEAE-4BA87E4E0B14Q35175999-F59C57C8-6D59-4A6E-A654-E7E5F588B70EQ35836868-50699F80-EA9C-444B-B2EC-D7CAA9916666Q36249853-7FAC155D-4635-4BF3-BA18-F6FBB7E5EC0EQ36708959-463E7CE7-7482-4260-B08B-CE0CDB382D58Q36989223-0D5C75BC-68D9-4A97-8987-F4922EAB0BCDQ37393337-CD3DA6FA-E648-42FA-A999-2DFC41B84DE0Q37420781-1DE819CA-6AF0-4C45-AC4E-1F2C22FF3807Q37683451-1E16CB31-85D7-4102-A22D-EDC16734CBF6Q37709259-63C91ACB-BA1E-4102-B79F-1A45B8126080Q38232067-76F04197-6F54-44E4-9DE4-7BA086FFDB0AQ38365227-D2F6DA33-4D7F-469C-B375-6672DA36DE0CQ38401664-0B813B19-0081-4B91-B15A-9F450DD8C965Q38700209-C219A8BB-8F56-4A47-9322-85D225FDD18CQ38821637-CBEA835A-08C1-45DF-8CED-166677D3D2BEQ38863136-1D6D6E19-76EC-4628-804E-47472193501CQ38947056-9C089B91-C81C-4972-8DEF-6C3F0424DDB5Q38981802-FF4685CA-9180-42B5-A3E3-74F8119F6780Q39064583-3AF0246E-AD34-4A21-999F-807C3D66C224Q42101040-DEE40840-9A37-419C-AEAB-E073872CBB45Q42545518-3E297494-12D4-4C93-8984-2E86EB81C8F3Q42700810-7CFA8425-60CD-4904-A0A0-2877B69B78D7Q45865484-E5B97278-84FB-4E6D-947B-097E4F89A778Q47094576-7BEB0F61-71CC-4509-811A-77816D1A411FQ47654279-2994BADF-9EC6-4247-A6DD-F7A376C893FFQ50002024-A71768C1-C44E-4DBE-93AE-D7DEDDD719BDQ51818965-0FEAFB0A-6C36-40F3-BCB0-FB794CA58E4FQ58122645-9AE2878F-72F6-41B0-9E8E-2B5983F25AA7Q58326827-19143C01-FEFB-408A-B0BE-FEBF6AE924C4
P2860
Role of CXCR4 in the pathogenesis of acute myeloid leukemia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Role of CXCR4 in the pathogenesis of acute myeloid leukemia.
@en
type
label
Role of CXCR4 in the pathogenesis of acute myeloid leukemia.
@en
prefLabel
Role of CXCR4 in the pathogenesis of acute myeloid leukemia.
@en
P2860
P921
P356
P1433
P1476
Role of CXCR4 in the pathogenesis of acute myeloid leukemia.
@en
P2093
Amnon Peled
Sigal Tavor
P2860
P356
10.7150/THNO.5150
P5008
P577
2013-01-13T00:00:00Z